The N6-Methyladenosine mRNA Methylase METTL3 Controls Cardiac Homeostasis and Hypertrophy

被引:342
|
作者
Dorn, Lisa E. [1 ]
Lasman, Lior [3 ]
Chen, Jing [4 ]
Xu, Xianyao [2 ]
Hund, Thomas J. [2 ]
Medvedovic, Mario [4 ]
Hanna, Jacob H. [3 ]
van Berlo, Jop H. [5 ,6 ]
Accornero, Federica [1 ]
机构
[1] Ohio State Univ, Dept Physiol & Cell Biol, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Biomed Engn, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA
[3] Weizmann Inst Sci, Dept Mol Genet, Rehovot, Israel
[4] Univ Cincinnati, Dept Environm Hlth, Div Biostat & Bioinformat, Cincinnati, OH 45221 USA
[5] Univ Minnesota, Div Cardiovasc, Lillehei Heart Inst, Minneapolis, MN 55455 USA
[6] Univ Minnesota, Stem Cell Inst, Minneapolis, MN USA
基金
英国医学研究理事会; 以色列科学基金会; 美国国家卫生研究院; 欧洲研究理事会;
关键词
gene expression profiling; hypertrophy; mice; transgenic; RNA processing; post-transcriptional; GENE-EXPRESSION; NUCLEAR-RNA; GROWTH; N6-METHYLADENOSINE;
D O I
10.1161/CIRCULATIONAHA.118.036146
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:N-6-Methyladenosine (m6A) methylation is the most prevalent internal posttranscriptional modification on mammalian mRNA. The role of m6A mRNA methylation in the heart is not known. Methods: To determine the role of m6A methylation in the heart, we isolated primary cardiomyocytes and performed m6A immunoprecipitation followed by RNA sequencing. We then generated genetic tools to modulate m6A levels in cardiomyocytes by manipulating the levels of the m6A RNA methylase methyltransferase-like 3 (METTL3) both in culture and in vivo. We generated cardiac-restricted gain- and loss-of-function mouse models to allow assessment of the METTL3-m6A pathway in cardiac homeostasis and function. Results: We measured the level of m6A methylation on cardiomyocyte mRNA, and found a significant increase in response to hypertrophic stimulation, suggesting a potential role for m6A methylation in the development of cardiomyocyte hypertrophy. Analysis of m6A methylation showed significant enrichment in genes that regulate kinases and intracellular signaling pathways. Inhibition of METTL3 completely abrogated the ability of cardiomyocytes to undergo hypertrophy when stimulated to grow, whereas increased expression of the m6A RNA methylase METTL3 was sufficient to promote cardiomyocyte hypertrophy both in vitro and in vivo. Finally, cardiac-specific METTL3 knockout mice exhibit morphological and functional signs of heart failure with aging and stress, showing the necessity of RNA methylation for the maintenance of cardiac homeostasis. Conclusions: Our study identified METTL3-mediated methylation of mRNA on N-6-adenosines as a dynamic modification that is enhanced in response to hypertrophic stimuli and is necessary for a normal hypertrophic response in cardiomyocytes. Enhanced m6A RNA methylation results in compensated cardiac hypertrophy, whereas diminished m6A drives eccentric cardiomyocyte remodeling and dysfunction, highlighting the critical importance of this novel stress-response mechanism in the heart for maintaining normal cardiac function.
引用
收藏
页码:533 / 545
页数:13
相关论文
共 50 条
  • [21] Acute depletion of METTL3 implicates N6-methyladenosine in alternative intron/exon inclusion in the nascent transcriptome
    Wei, Guifeng
    Almeida, Mafalda
    Pintacuda, Greta
    Coker, Heather
    Bowness, Joseph S.
    Ule, Jernej
    Brockdorff, Neil
    GENOME RESEARCH, 2021, 31 (08) : 1395 - 1408
  • [22] N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2
    Wang, Hong
    Xu, Bei
    Shi, Jun
    GENE, 2020, 722
  • [23] METTL3 Reduces Oxidative Stress-induced Apoptosis in Presbycusis by Regulating the N6-methyladenosine Level of SIRT1 mRNA
    Wang, Enhao
    Li, Yang
    Li, Hejie
    Liu, Yingzhao
    Ming, Ruijie
    Wei, Jiahui
    Du, Peiyu
    Li, Xiangrui
    Zong, Shimin
    Xiao, Hongjun
    NEUROSCIENCE, 2023, 521 : 110 - 122
  • [24] Prognostic Roles of N6-Methyladenosine METTL3 in Different Cancers: A System Review and Meta-Analysis
    Liu, KuangZheng
    Gao, Yue
    Gan, Kai
    Wu, YuQing
    Xu, Bin
    Zhang, LiHua
    Chen, Ming
    CANCER CONTROL, 2021, 28
  • [25] METTL3-mediated mRNA N6-methyladenosine is required for oocyte and follicle development in mice
    Mu, Haiyuan
    Zhang, Ting
    Yang, Ying
    Zhang, Danru
    Gao, Jie
    Li, Junhong
    Yue, Liang
    Gao, Dengfeng
    Shi, Bingbo
    Han, Yue
    Zhong, Liang
    Chen, Xinze
    Wang, Zhen-Bo
    Lin, Zhen
    Tong, Ming-Han
    Sun, Qing-Yuan
    Yang, Yun-Gui
    Han, Jianyong
    CELL DEATH & DISEASE, 2021, 12 (11)
  • [26] METTL3-mediated mRNA N6-methyladenosine is required for oocyte and follicle development in mice
    Haiyuan Mu
    Ting Zhang
    Ying Yang
    Danru Zhang
    Jie Gao
    Junhong Li
    Liang Yue
    Dengfeng Gao
    Bingbo Shi
    Yue Han
    Liang Zhong
    Xinze Chen
    Zhen-Bo Wang
    Zhen Lin
    Ming-Han Tong
    Qing-Yuan Sun
    Yun-Gui Yang
    Jianyong Han
    Cell Death & Disease, 12
  • [27] N6-methyladenosine (m6A) writer METTL3 accelerates the apoptosis of vascular endothelial cells in high glucose
    Li, Zhenjin
    Meng, Xuying
    Chen, Yu
    Xu, Xiaona
    Guo, Jianchao
    HELIYON, 2023, 9 (03)
  • [28] The N6-methyladenosine mRNA methylase METTL14 promotes renal ischemic reperfusion injury via suppressing YAP1
    Xu, Yao
    Yuan, Xiao Dong
    Wu, Jia Jin
    Chen, Ruo Yang
    Xia, Lei
    Zhang, Ming
    Han, Cong Hui
    Mou, Shan
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2020, 121 (01) : 524 - 533
  • [29] N6-methyladenosine methyltransferase METTL3 promotes colorectal cancer cell proliferation through enhancing MYC expression
    Xiang, Song
    Liang, Xiaolong
    Yin, Shuo
    Liu, Jian
    Xiang, Zheng
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (05): : 1789 - 1806
  • [30] RNA N6-METHYLADENOSINE METHYLTRANSFERASE METTL3 DRIVES NAFLD-HCC THROUGH SUPPRESSING ANTITUMOR IMMUNITY
    Pan, Yasi
    Chen, Huarong
    Wong, Chi Chun
    Zhang, Xiang
    Liu, Weixin
    Ding, Yanqiang
    Huang, Dan
    Song, Qian
    Yu, Jun
    GASTROENTEROLOGY, 2022, 162 (07) : S1123 - S1123